UFP Technologies Inc (UFPT) is a publicly traded Healthcare sector company. As of May 21, 2026, UFPT trades at $224.73 with a market cap of $1.68B and a P/E ratio of 24.91. UFPT moved +1.74% today. Year to date, UFPT is -5.30%; over the trailing twelve months it is -6.09%. Its 52-week range spans $173.86 to $354.22. Analyst consensus is buy with an average price target of $289.00. Rallies surfaces UFPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading UFPT stock inside the company?
Recent UFPT insider activity includes CROTEAU DANIEL C sold 2.86K, Holt Jason sold 100, Litterio Christopher P. sold 47, Litterio Christopher P. sold 175, and Litterio Christopher P. sold 390. Rallies tracks insider transaction dates, shares, prices, and estimated values.
UFPT Key Metrics
Key financial metrics for UFPT
Metric
Value
Price
$224.73
Market Cap
$1.68B
P/E Ratio
24.91
EPS
$8.90
Dividend Yield
0.00%
52-Week High
$354.22
52-Week Low
$173.86
Volume
0
Avg Volume
0
Revenue (TTM)
$608.85M
Net Income
$68.62M
Gross Margin
28.35%
Recent UFPT Insider Trades
CROTEAU DANIEL C sold 2.86K (~$634.98K) on May 12, 2026.
Holt Jason sold 100 (~$21.36K) on Dec 10, 2025.
Litterio Christopher P. sold 47 (~$10.33K) on Nov 6, 2025.
Litterio Christopher P. sold 175 (~$38.74K) on Nov 6, 2025.
Litterio Christopher P. sold 390 (~$86.62K) on Nov 6, 2025.
Recent UFPT insider activity includes CROTEAU DANIEL C sold 2.86K, Holt Jason sold 100, Litterio Christopher P. sold 47, Litterio Christopher P. sold 175, and Litterio Christopher P. sold 390. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for UFPT?
Yes. Rallies tracks UFPT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is UFPT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UFPT. It does not provide personalized investment advice.